Question 1

What specific safety information will be collected during this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) clinical trial (NCT04618081). Contact the study team or your healthcare provider for specific answers.

Question 2

How does Revlimid® compare to other treatments I might consider?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) clinical trial (NCT04618081). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of Revlimid® that I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) clinical trial (NCT04618081). Contact the study team or your healthcare provider for specific answers.

Question 4

How long will I need to participate in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) clinical trial (NCT04618081). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while on Revlimid®?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) clinical trial (NCT04618081). Contact the study team or your healthcare provider for specific answers.

What this study is about